BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
Biotech catalysts in 2027-03
0 industry Phase 2/3 trial readout(s) and 4 FDA decision event(s). Active trials only; estimated dates often slip.
FDA decision events
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| 2027-03-10 | PDUFA date (company-disclosed) | pending | Intellia Therapeutics, Inc. NTLA | PDUFA MARCH 10, 2027 - Intellia Therapeutics, Inc. | |
| 2027-03-16 | PDUFA date (company-disclosed) | pending | Aquestive Therapeutics, Inc. AQST | PDUFA March 16, 2027 - Aquestive Therapeutics, Inc. | |
| 2027-03-25 | PDUFA date (company-disclosed) | pending | Unicycive Therapeutics, Inc. UNCY | PDUFA March 25, 2027 - Unicycive Therapeutics, Inc. | |
| 2027-03-31 | PDUFA date (company-disclosed) | pending | Atara Biotherapeutics, Inc. ATRA | PDUFA March 31, 2027 - Atara Biotherapeutics, Inc. |
Trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| No trials in this window. | ||||||
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.